G Taliani

Summary

Affiliation: University of Rome La Sapienza
Country: Italy

Publications

  1. ncbi request reprint Serum concentration of gammaGT is a surrogate marker of hepatic TNF-alpha mRNA expression in chronic hepatitis C
    Gloria Taliani
    DISP LITA Vialba, University of Milan, 20157, Milan, Italy
    Clin Immunol 105:279-85. 2002
  2. pmc IL28B gene polymorphisms and US liver fatty changes in patients who spontaneously cleared hepatitis C virus infection
    Gloria Taliani
    Clinica Malattie Infettive e Tropicali, Department of Clinical Medicine, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
    PLoS ONE 8:e67301. 2013
  3. pmc Early monitoring of the human polyomavirus BK replication and sequencing analysis in a cohort of adult kidney transplant patients treated with basiliximab
    Elena Anzivino
    Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy
    Virol J 8:407. 2011
  4. pmc Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha
    Carolina Scagnolari
    Department of Molecular Medicine, Laboratory of Virology, Sapienza University of Rome Rome, Italy
    Virol J 7:311. 2010
  5. ncbi request reprint Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection
    G Taliani
    Department of Infectious and Tropical Diseases, University La Sapienza of Rome, Rome, Italy
    J Viral Hepat 14:875-82. 2007
  6. ncbi request reprint Fatal acute hepatitis C virus infection in patients with hematological malignancies
    G Taliani
    University of Rome, Italy
    J Chemother 18:662-4. 2006
  7. ncbi request reprint Pegylated interferon alfa-2b plus ribavirin in the retreatment of interferon-ribavirin nonresponder patients
    Gloria Taliani
    Department of Infectious and Tropical Diseases, La Sapienza University, Rome, Italy
    Gastroenterology 130:1098-106. 2006
  8. doi request reprint Polyomavirus BK infection before liver transplantation in patients with chronic kidney disease
    A P Mitterhofer
    Department of Clinical Medicine, Nephrology and Dialysis Unit, 1st Faculty of Medicine and Surgery, Sapienza University of Rome, Rome, Italy
    Transplant Proc 44:1934-7. 2012
  9. doi request reprint Polyomavirus BK replication in adult polycystic kidney disease post-renal transplant patients and possible role of cellular permissivity
    A P Mitterhofer
    Department of Clinical Medicine, Nephrology and Dialysis Unit, Sapienza University of Rome, Rome, Italy
    Transplant Proc 43:1048-51. 2011
  10. doi request reprint Polyomavirus BK replication in liver transplant candidates with normal renal function
    A P Mitterhofer
    Department of Clinical Medicine, Nephrology and Dialysis Unit, Sapienza University of Rome, Rome, Italy
    Transplant Proc 43:1142-4. 2011

Collaborators

Detail Information

Publications21

  1. ncbi request reprint Serum concentration of gammaGT is a surrogate marker of hepatic TNF-alpha mRNA expression in chronic hepatitis C
    Gloria Taliani
    DISP LITA Vialba, University of Milan, 20157, Milan, Italy
    Clin Immunol 105:279-85. 2002
    ..79, P < 0.0001). These findings suggest that serum gammaGT levels may represent a surrogate marker of hepatic TNF-alpha expression, thus explaining the importance of serum gammaGT levels in predicting treatment outcome...
  2. pmc IL28B gene polymorphisms and US liver fatty changes in patients who spontaneously cleared hepatitis C virus infection
    Gloria Taliani
    Clinica Malattie Infettive e Tropicali, Department of Clinical Medicine, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
    PLoS ONE 8:e67301. 2013
    ..Moreover, IL28B polymorphism seems to influence the probability of developing liver steatosis in chronic HCV patients...
  3. pmc Early monitoring of the human polyomavirus BK replication and sequencing analysis in a cohort of adult kidney transplant patients treated with basiliximab
    Elena Anzivino
    Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy
    Virol J 8:407. 2011
    ..We also performed sequencing analysis to assess whether a particular BKV subtype/subgroup or transcriptional control region (TCR) variants were present...
  4. pmc Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha
    Carolina Scagnolari
    Department of Molecular Medicine, Laboratory of Virology, Sapienza University of Rome Rome, Italy
    Virol J 7:311. 2010
    ..Given the importance of miRNAs in defending the host against virus infections, it is possible that IFN-induced miRNAs may represent an important determinant of the clinical outcome of IFN therapy in HCV infection...
  5. ncbi request reprint Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection
    G Taliani
    Department of Infectious and Tropical Diseases, University La Sapienza of Rome, Rome, Italy
    J Viral Hepat 14:875-82. 2007
    ..Conclusions: Treatment history and expectations and physical comorbidity may affect QOL in HCV-positive patients. Untreated and relapsed patients have comparable levels of QOL and higher scores than NR...
  6. ncbi request reprint Fatal acute hepatitis C virus infection in patients with hematological malignancies
    G Taliani
    University of Rome, Italy
    J Chemother 18:662-4. 2006
    ..Prospective studies are needed to define the frequency of fatal acute HCV infection among hematologic patients undergoing chemotherapy...
  7. ncbi request reprint Pegylated interferon alfa-2b plus ribavirin in the retreatment of interferon-ribavirin nonresponder patients
    Gloria Taliani
    Department of Infectious and Tropical Diseases, La Sapienza University, Rome, Italy
    Gastroenterology 130:1098-106. 2006
    ..Treatment up to 48 weeks also in patients who have failed to clear hepatitis C virus (HCV) RNA by week 24 was also evaluated...
  8. doi request reprint Polyomavirus BK infection before liver transplantation in patients with chronic kidney disease
    A P Mitterhofer
    Department of Clinical Medicine, Nephrology and Dialysis Unit, 1st Faculty of Medicine and Surgery, Sapienza University of Rome, Rome, Italy
    Transplant Proc 44:1934-7. 2012
    ..The specific immunologic mechanisms involved in pretransplantation diseases may have a role in BKV reactivation that could become responsible for nephropathy after transplantation...
  9. doi request reprint Polyomavirus BK replication in adult polycystic kidney disease post-renal transplant patients and possible role of cellular permissivity
    A P Mitterhofer
    Department of Clinical Medicine, Nephrology and Dialysis Unit, Sapienza University of Rome, Rome, Italy
    Transplant Proc 43:1048-51. 2011
    ..We hypothesized that the lower number of patients with active BKV plasma replication in the Pc group may be related to a lower cellular permissivity of the renal tubular epithelial cells in ADPKD...
  10. doi request reprint Polyomavirus BK replication in liver transplant candidates with normal renal function
    A P Mitterhofer
    Department of Clinical Medicine, Nephrology and Dialysis Unit, Sapienza University of Rome, Rome, Italy
    Transplant Proc 43:1142-4. 2011
    ..In BK virus reactivation, not only the immunodepressive state itself, but also the specific immunologic mechanisms involved may have a role...
  11. doi request reprint Polyomavirus BK infection in end-stage renal disease: analysis of viral replication in patients on hemodialysis or peritoneal dialysis
    A P Mitterhofer
    Department of Clinical Medicine, Nephrology and Dialysis Unit, Sapienza University of Rome, Rome, Italy
    Transplant Proc 44:1869-72. 2012
    ..PD is an option that could be associated with a better transplant outcome for patients undergoing kidney transplantation...
  12. doi request reprint Acute hepatitis B in patients with or without underlying chronic HCV infection
    E Biliotti
    Department of Infectious and Tropical Diseases, University La Sapienza of Rome, Italy
    J Infect 57:152-7. 2008
    ..The aim of this study was to compare clinical and virological characteristics of acute hepatitis B in patients with or without chronic hepatitis C virus (HCV) infection...
  13. ncbi request reprint Reversible alopecia universalis during treatment with PEG-interferon and ribavirin for chronic hepatitis C
    G Taliani
    Clinica Malattie Infettive e Tropicali, Universita degli Studi di Firenze, Italy
    J Chemother 17:212-4. 2005
    ..However, given the benign and reversible nature of this side effect, patients who achieve a virological response should be strongly advised to complete the treatment in order to prevent disease relapse...
  14. ncbi request reprint Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy
    A Mele
    Clinical Epidemiology Unit, Istituto Superiore di Sanita, Rome, Italy
    J Infect Dis 184:905-8. 2001
    ..There is no evidence that the emergence of HBV escape mutants secondary to the immune pressure against wild-type HBV is of concern...
  15. doi request reprint Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients
    E Riva
    Department of Biomedical Research, University Campus Bio Medico, Via E Longoni n 47, 00185, Rome, Italy
    Med Microbiol Immunol 198:13-8. 2009
    ..Collectively, these findings strengthen the possibility that IC virus could play a critical role in the pathogenesis of HCV infection...
  16. ncbi request reprint Risk management of HBsAg or anti-HCV positive healthcare workers in hospital
    A Mele
    Institute of Health, L Spallanzani Hospital, Italian Association for the Study of the Liver, Rome, Italy
    Dig Liver Dis 33:795-802. 2001
    ..If exposure to hepatitis B virus occurs, the healthcare worker must undergo prophylaxis with specific immunoglobulins, in addition to vaccination...
  17. doi request reprint Meaning of early polyomavirus-BK replication post kidney transplant
    A P Mitterhofer
    Department of Nephro urology, 1st Faculty of Medicine and Surgery, Sapienza University of Rome, Rome, Italy
    Transplant Proc 42:1142-5. 2010
    ..This condition seemed to be the most important risk factor for persistent infection in the first 6 months...
  18. ncbi request reprint [Retreatment of chronic hepatitis C patients non responder to a previous antiviral treatment]
    Gloria Taliani
    Dipartimento di Malattie Infettive e Tropicali, Universita La Sapienza, Roma
    Recenti Prog Med 98:219-24. 2007
    ..Although these new strategies have produced variable results, they remain the cornerstone of retreatment in view of forthcoming new antiviral drugs...
  19. ncbi request reprint Quality of life assessment in chronic liver disease
    Rosalia Cirrincione
    Laboratorio di Epidemiologia e Biostatistica Istituto Superiore di Sanità, Viale Regina Elena 299, Roma 00161, Italy
    Hepatogastroenterology 49:813-6. 2002
    ....
  20. ncbi request reprint Hepatitis A vaccine failure: how to treat the threat
    Gloria Taliani
    Vaccine 21:4505-6. 2003
  21. ncbi request reprint Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection
    Silvia Guglietta
    Department of Cellular and Developmental Biology University of Rome La Sapienza, Rome, Italy
    Eur J Immunol 35:2627-37. 2005
    ..These results support the view that acute-phase CD8+ T cell responses exert a biologically relevant pressure on HCV replication and that viruses escaping this host response could have a significant survival advantage...